AVTXVSCNTX• 12 Months (Normalized)
AVTX vs CNTX (Avalo Therapeutics Inc. vs Context Therapeutics Inc.)
Showing Closing Date Range from Sep, 18, 2025 to Sep, 18, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
AVTX Performance $16.57
+39.48%
Avalo Therapeutics Inc.
Normalized Baseline0.00%
CNTX Performance $0.37
-63.19%
Context Therapeutics Inc.
Normalized Baseline0.00%
Alpha Spread Margin AVTX LEADS
+102.67%
AVTX outperforming by 102.67%
AVTXCNTX
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
AVTX CNTX
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(252 dates)
| Date | AVTX Price | AVTX Gain (%) | CNTX Price | CNTX Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 18, 2026 | $16.57 | +39.48% | $0.37 | -63.19% | +102.67% |
| Sep 17, 2026 | $16.69 | +40.49% | $0.38 | -61.70% | +102.19% |
| Sep 16, 2026 | $16.58 | +39.56% | $0.38 | -62.10% | +101.66% |
| Sep 15, 2026 | $16.07 | +35.27% | $0.36 | -63.60% | +98.87% |
| Sep 14, 2026 | $16.18 | +36.20% | $0.35 | -64.90% | +101.10% |
| Sep 11, 2026 | $16.12 | +35.69% | $0.35 | -65.00% | +100.69% |
| Sep 10, 2026 | $17.18 | +44.61% | $0.37 | -63.40% | +108.01% |
| Sep 09, 2026 | $18.21 | +53.28% | $0.37 | -63.00% | +116.28% |
| Sep 08, 2026 | $19.71 | +65.91% | $0.38 | -62.40% | +128.31% |
| Sep 04, 2026 | $19.23 | +61.87% | $0.36 | -63.80% | +125.67% |
| Sep 03, 2026 | $19.00 | +59.93% | $0.36 | -63.70% | +123.63% |
| Sep 02, 2026 | $19.34 | +62.79% | $0.36 | -63.70% | +126.49% |
| Sep 01, 2026 | $18.95 | +59.51% | $0.36 | -63.60% | +123.11% |
| Aug 31, 2026 | $19.34 | +62.79% | $0.39 | -61.00% | +123.79% |
| Aug 28, 2026 | $19.59 | +64.90% | $0.38 | -61.60% | +126.50% |
Page 1 of 17